1453 
Masimo has announced the CE marking of the Rad-97™ Pulse CO-Oximeter® with integrated NomoLine™ capnography.
With this clearance, Rad-97 is now available both within and outside the United States in three configurations: Rad-97, Rad-97 with integrated noninvasive blood pressure, and now Rad-97 with NomoLine capnography. Rad-97 offers Masimo noninvasive and continuous monitoring, through Measure-through Motion and Low Perfusion™ SET® pulse oximetry, upgradeable rainbow® technology, and NomoLine capnography in a compact, standalone monitor that incorporates advanced customisability, connectivity, and device integration capabilities.
Rad-97 with NomoLine capnography features an integrated ISA™ CO2 module with NomoLine sampling lines for sidestream capnography, with an adapter for intubated patients – meeting continuous monitoring and capnography needs in a single device. Rad-97 with capnography displays continuous end-tidal carbon dioxide (EtCO2) values with numeric, trend, and waveform viewing options, as well as fractional concentration of inspired carbon dioxide (FiCO2) and respiration rate. With both integrated capnography and Masimo acoustic respiration rate (RRa®) available on a single device, clinicians have the flexibility of choosing the most appropriate respiration monitoring method for each patient.
Rad-97 combines its portable, compact form factor with a high-resolution, multi-touch color display that allows clinicians to easily customise the device for each monitoring use case – bringing rainbow SET™ measurements and capnography measurements to care areas where a small footprint or high portability is desired. Rad-97 features built-in enterprise WiFi capability, allowing it to connect wirelessly to supplemental patient monitoring systems including Masimo Patient SafetyNet™*, facilitating automatic data transfer to hospital electronic medical record (EMR) systems. The easy-to-use, intuitive interface helps to simplify charting workflows for vital sign monitoring and patient data capture.
“We’re delighted to bring the full family of Rad-97 products to markets outside the United States,” said Joe Kiani, Founder and CEO of Masimo. “We believe Rad-97, with its versatility and customisability, will play an especially important role in helping hospitals improve their monitoring capabilities with convenient, easy-to-use device and technology solutions – ultimately helping to improve patient care and safety.”
